Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) dedicated to accelerating the development of vaccines, biologics, and advanced therapeutics through high-quality analytical and bioanalytical services. With more than a decade of experience, Avance delivers CGMP, GLP, and CLIA-compliant solutions spanning assay development, validation, and regulated sample testing across preclinical, clinical, and manufacturing stages. Our expertise integrates cutting-edge technologies, such as real-time PCR, ddPCR, next-generation sequencing, immunoassays, and flow cytometry, to rigorously assess product safety, potency, immunogenicity, and regulatory readiness. Based in Houston, Texas, Avance serves a global biotechnology and pharmaceutical client base, offering tailored support across diverse modalities including vaccines, viral and non-viral gene therapies, cell therapies, monoclonal antibodies, and small molecules. We partner with developers worldwide to deliver reliable data and scientific insight that de-risk programs and help advance breakthrough medical products toward regulatory approval and patient impact.
https://www.avancebio.com/modality/vaccines/